temelimab 54 mg/kg

DRUG2 trials

Sponsors

GeNeuro Innovation SAS

Conditions

Multiple Sclerosis

Phase 2

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis

CompletedNCT04480307

GeNeuro Innovation SASMultiple Sclerosis

Start: 2020-06-17End: 2022-01-24Updated: 2024-11-07

A Long-term Extension of Study GNC-401

TerminatedNCT05049161

GeNeuro Innovation SASMultiple Sclerosis

Start: 2021-08-27End: 2022-05-18Updated: 2022-07-07